Three Minutes with a Skeptical Oncologist: Inside ACTO’s AI Engine for HCP-Ready Reps

As shrinking HCP access, soaring therapeutic complexity and data overload redefine pharma’s commercial model, ACTO’s CEO and Co-founder Parth Khanna argues that “generic sales tools” are no longer fit for...